FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

AL Durol

Research Profile

Chemicals & Drugs

Procedures

Concepts & Ideas

Half-Life

Phenomena

Anatomy

Microsomes, Liver

Co-author Network

Publications

TOP 3
Lisa L Von Moltke; AL Durol; Su X Duan; David J Greenblatt
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.
David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Differential impairment of triazolam and zolpidem clearance by ritonavir.
David J Greenblatt; Jerold S Harmatz; Lisa L Von Moltke; C Eugene Wright; AL Durol; L M Harrel-Joseph; Richard I Shader
Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of AL Durol (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Lisa L Von Moltke; AL Durol; Su X Duan; David J Greenblatt
Potent mechanism-based inhibition of human CYP3A in vitro by amprenavir and ritonavir: comparison with ketoconazole.
European journal of clinical pharmacology 2000;56(3):259-61.
2000: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Differential impairment of triazolam and zolpidem clearance by ritonavir.
Journal of acquired immune deficiency syndromes (1999) 2000;24(2):129-36.
2000: David J Greenblatt; Jerold S Harmatz; Lisa L Von Moltke; C Eugene Wright; AL Durol; L M Harrel-Joseph; Richard I Shader
Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.
The Journal of pharmacology and experimental therapeutics 2000;293(2):435-43.
2000: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; AL Durol; Johanna Daily; Jennifer A Graf; Polyxane Mertzanis; J L Hoffman; Richard I Shader
Alprazolam-ritonavir interaction: implications for product labeling.
Clinical pharmacology and therapeutics 2000;67(4):335-41.
1999: Tsutomu Kotegawa; Bart E Laurijssens; AL Durol; David J Greenblatt
Pharmacokinetics and electroencephalographic effects of ketoconazole in the rat.
Biopharmaceutics & drug disposition 1999;20(1):49-52.
1998: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; Polyxane Mertzanis; Jennifer A Graf; AL Durol; M Counihan; B Roth-Schechter; Richard I Shader
Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
Clinical pharmacology and therapeutics 1998;64(6):661-71.
1998: David J Greenblatt; Lisa L Von Moltke; Jerold S Harmatz; M Counihan; Jennifer A Graf; AL Durol; Polyxane Mertzanis; Su X Duan; C Eugene Wright; Richard I Shader
Inhibition of triazolam clearance by macrolide antimicrobial agents: in vitro correlates and dynamic consequences.
Clinical pharmacology and therapeutics 1998;64(3):278-85.
1997: AL Durol; David J Greenblatt
Analysis of zolpidem in human plasma by high-performance liquid chromatography with fluorescence detection: application to single-dose pharmacokinetic studies.
Journal of analytical toxicology 1997;21(5):388-92.